Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors

A series of 4,4-disubstituted quinolinones was prepared and evaluated as HIV-1 reverse transcriptase inhibitors. The C-3 substituted compound 9h displayed improved antiviral activity against clinically significant single (K103N) and double (K103N/L100I) mutant viruses. (C) 2001 DuPont Pharmaceuticals Company. Published by Elsevier Science Ltd. Ail rights reserved.